logo
It's Alive!

It's Alive!

New York Times09-07-2025
Couture, the oldest and most elite of the fashion arts, the pieces made by hand for the very few, can sometimes seem like a fossil preserved in an amber corset. Which is why Iris van Herpen's work, both futuristic and deliberately kinetic, has always been so mesmerizing: skirts that jounce like jellyfish, extrusions that tremble like palm fronds, and sleeves (or sleeve-like appendages) that flutter like butterfly wings.
Even by her standards, however, the second look in the couture collection she showed in Paris was something else.
It was actually alive.
Made of 125 million bioluminescent algae known as Pyrocystis lunula that glow in response to movement (think the luminescent plankton that can make the ocean seem lit from within), the dress-and-leggings combination was grown in an gelatinlike substance that was then molded into one of Ms. van Herpen's signature sci-fi anatomical lattice frocks. Wearing it, the model resembled a very regal, otherworldly crustacean.
It had an aquatic tint and a vaguely squishy, jellylike veneer. And though it didn't exactly radiate megawatt beams when the model walked, it did emanate a soft blue haze. According to Ms. van Herpen, the look feels sort of visceral when worn. And for anyone wondering, it was not smelly.
More of an experiment than an actual for-sale item, the outfit was, Ms. van Herpen said backstage, 'the next step in not being inspired by nature, but collaborating with nature.'
Want all of The Times? Subscribe.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

āshibio licences vantictumab for rare bone disorder
āshibio licences vantictumab for rare bone disorder

Yahoo

time12 minutes ago

  • Yahoo

āshibio licences vantictumab for rare bone disorder

Biotechnology company āshibio has entered an exclusive licencing agreement with Mereo BioPharma for the monoclonal antibody, vantictumab, to treat a rare bone disorder. The agreement aims to facilitate antibody development for the autosomal dominant osteopetrosis type 2 (ADO2) bone condition that currently lacks approved therapies. āshibio will oversee clinical development of vantictumab globally for both adult and paediatric patients. Mereo has granted exclusive rights to āshibio for the development and commercialisation in the US and other regions outside of Europe, where Mereo retains commercial rights. ADO2, also referred to as Albers-Schönberg disease, is a genetic disorder characterised by reduced osteoclast function, leading to dense and brittle bones. It is linked to mutations in the chloride channel 7 (CLCN7) gene, with an incidence rate of one in 20,000 births. Āshibio CEO Pankaj Bhargava stated: 'People living with autosomal dominant osteopetrosis type 2 face a lifetime of bone-related complications resulting in significant morbidity, multiple surgical procedures, chronic pain and impaired quality of life – yet patients have no approved therapy to address the disease. 'Bringing vantictumab into our pipeline reflects our commitment to advancing therapies for rare skeletal conditions and improving the lives of those affected by serious bone disorders.' Vantictumab functions by selectively binding to specific frizzled (Fzd) receptors and inhibiting Wnt (wingless-related integration) signalling pathways. Initially developed for cancer treatment, it has undergone clinical trials in oncology showing a favourable safety and pharmacokinetic profile. Previous studies have generated biomarker data that support the efficacy of vantictumab on osteoclast function, which aids in reducing risks associated with the clinical programme and allows āshibio to expedite the advancement of vantictumab into clinical trials for ADO2. "āshibio licences vantictumab for rare bone disorder" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site.

Youtubers wins live UK Broadcasting Rights to Bundesliga
Youtubers wins live UK Broadcasting Rights to Bundesliga

Yahoo

time12 minutes ago

  • Yahoo

Youtubers wins live UK Broadcasting Rights to Bundesliga

Youtube channels, That's Football, hosted by Mark Goldbridge, and The Overlap have won UK broadcast rights to show the Bundesliga live this season, according to The Athletic. Alongside the BBC and Amazon Prime, The Overlap and That's Football, will share live broadcasting rights, showing 20 live Friday night games. The Overlap is a British-based YouTube channel with former players, Gary Neville, Jamie Carragher, Jill Scott, Ian Wright, and Roy Keane and has over 1.5m subscribers. That's Football is the Mark Goldbridge football fan channel and has over 1.4m subscribers. The new agreement is due to be announced today and makes the Bundesliga the first major European football league to award part of its live broadcasting rights in the United Kingdom to Youtube content creators. This is part of an emerging trend away from traditional broadcasting models. Recently, The Rest is Football became the first UK platform of its kind to secure a highlights package with Spain's La Liga. Importantly for UK-based Bundesliga fans, all games will be free-to-air apart from those on Amazon Prime. Sunday games on Amazon Prime will be pay-per-view for £2.49. The Bundesliga's own YouTube channel will also be live broadcasting all Friday night games in the Bundesliga and the second tier of German football. The move may disappoint traditional Bundesliga fans in the UK. Sky Sports has been the long-term Bundesliga provider. Their deal has now ended, but Sky will retain the rights to the Saturday evening game. The move is part of a Bundesliga strategy to attract a new and younger global audience. On Youtube, Goldbridge's channel regularly attracts over 250,000 viewers, with a high of one million. The Overlap's most recent video attracted over 1.5 million, with previous highs of over 8 million. Given their popularity and global reach with younger audiences, the Bundesliga will be excited about the prospects of this new venture. The Bundesliga kicks off this Friday with reigning Champions, Bayern Munich welcoming RB Leipzig to Bavaria. You will be able to follow along to all the latest news, previews, and action right here with GGFN. GGFN | Oscar O'Mara

Serbian scientists experiment with mealworms to degrade polystyrene
Serbian scientists experiment with mealworms to degrade polystyrene

Yahoo

time12 minutes ago

  • Yahoo

Serbian scientists experiment with mealworms to degrade polystyrene

Serbian scientists experiment with mealworms to degrade polystyrene BELGRADE (Reuters) -Serbian scientists have been experimenting with mealworms as a way to break down polystyrene. Larisa Ilijin, a principal research fellow at Belgrade's Institute for Biology, said the scientists had discovered that mealworms can digest various plastics, including polystyrene, which is used in packaging, insulation and food containers. In the project endorsed by the government and the United Nations' agency for international development, UNDP, and other international donors, they have been including the polystyrene in the regular food of the larval form of the yellow mealworm beetle, or Tenebrio molitor. They habitually eat more or less anything, but need the training to eat the plastic products. "We have larvae that have been adapted over a long time to biodegrade plastic, to be as efficient as possible in the process," Ilijin told Reuters. She said the bacteria living in their guts break down the plastic into carbon dioxide and water, and showed no evidence of leaving microplastic residue in their innards or faeces. The work builds on similar research projects in the U.S. and Africa. Serbia, which hopes to join the EU, recycles only 15% of municipal waste, far below the EU's 55% target and less than 2% of household waste. Over 84% of waste ends up in about 3,000 landfill sites, often unregulated and filled with plastic, cardboard, paper and organic waste. It is looking for ways to meet EU waste treatment standards. "Styrofoam takes over 500 years to decompose in nature ... this would be one of the good ways for solving the problem of plastic waste in nature," Ilijin said. The institute has given Belgrade-based Belinda Animals several containers of the mealworms. It is now breeding them and hoping to attract a network of similar farms. 'When breaking down 1 kg of Styrofoam, larvae emit one to two grams of carbon dioxide ... If we incinerate it ... (Styrofoam) emits over 4,000 times more,' owner Boris Vasiljev said. He also envisages the larvae being used as animal feed, should it reach a large commercial scale. The use of mealworms is still in its infancy, Ilijin said, as Serbia still needs to adopt regulations that would allow the use and sale of insect products for animal fodder. Solve the daily Crossword

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store